AR039176A1 - Nuevo compuesto - Google Patents
Nuevo compuestoInfo
- Publication number
- AR039176A1 AR039176A1 ARP030101089A ARP030101089A AR039176A1 AR 039176 A1 AR039176 A1 AR 039176A1 AR P030101089 A ARP030101089 A AR P030101089A AR P030101089 A ARP030101089 A AR P030101089A AR 039176 A1 AR039176 A1 AR 039176A1
- Authority
- AR
- Argentina
- Prior art keywords
- new compound
- amino
- methyl
- compound
- ethylbenzamide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- LVBWNCGBKNOVQX-IBGZPJMESA-N 3-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-ethylbenzamide Chemical compound CCNC(=O)C1=CC=CC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 LVBWNCGBKNOVQX-IBGZPJMESA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto de fórmula (1), que es: 3-({[({[(2S)-4-(3,4-diclorobencil)morfolin-2-il]metil}amino)carbonil]amino}metil)-N-etilbenzamida; y sus sales y solvatos; un procedimiento de preparación, formulaciones farmacéuticas que lo contienen y su uso en terapia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207447.4A GB0207447D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039176A1 true AR039176A1 (es) | 2005-02-09 |
Family
ID=9933997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101089A AR039176A1 (es) | 2002-03-28 | 2003-03-27 | Nuevo compuesto |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1490345A2 (es) |
| JP (1) | JP2006504626A (es) |
| AR (1) | AR039176A1 (es) |
| AU (1) | AU2003226758A1 (es) |
| GB (1) | GB0207447D0 (es) |
| TW (1) | TW200401771A (es) |
| WO (1) | WO2003082834A2 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870074A (en) * | 1986-04-30 | 1989-09-26 | Dainippon Pharmaceutical Co., Ltd. | Substituted benzamide derivatives, for enhancing gastrointestinal motility |
| EP0760362B1 (en) * | 1994-05-18 | 2002-08-14 | Nisshin Seifun Group Inc. | diaminomethylidene derivative |
| DE69511086T2 (de) * | 1994-05-18 | 2000-01-05 | Nisshin Flour Milling Co., Ltd. | Pyrimidinderivate |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| BR0114321A (pt) * | 2000-09-29 | 2003-07-01 | Glaxo Group Ltd | Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto |
-
2002
- 2002-03-28 GB GBGB0207447.4A patent/GB0207447D0/en not_active Ceased
-
2003
- 2003-03-26 TW TW092106774A patent/TW200401771A/zh unknown
- 2003-03-27 AU AU2003226758A patent/AU2003226758A1/en not_active Abandoned
- 2003-03-27 EP EP03745295A patent/EP1490345A2/en not_active Withdrawn
- 2003-03-27 AR ARP030101089A patent/AR039176A1/es unknown
- 2003-03-27 WO PCT/EP2003/003338 patent/WO2003082834A2/en not_active Ceased
- 2003-03-27 JP JP2003580302A patent/JP2006504626A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003082834A2 (en) | 2003-10-09 |
| TW200401771A (en) | 2004-02-01 |
| WO2003082834A3 (en) | 2004-03-25 |
| EP1490345A2 (en) | 2004-12-29 |
| AU2003226758A1 (en) | 2003-10-13 |
| AU2003226758A8 (en) | 2003-10-13 |
| JP2006504626A (ja) | 2006-02-09 |
| GB0207447D0 (en) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2861070B1 (fr) | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique | |
| FR2861071B1 (fr) | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique | |
| PA8529501A1 (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7." | |
| PA8518801A1 (es) | Derivados de 2-aminocarbonil-9h-purina | |
| TR200201874T2 (tr) | Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler. | |
| ATE304347T1 (de) | Selbstbräunendes mittel enthaltend einen ester von einer n-acyl aminosäure | |
| DK1629824T3 (da) | Nye koblingskomponenter | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| SE0400043D0 (sv) | New compounds | |
| FR2848116B1 (fr) | Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide. | |
| BR0314844A (pt) | Novo composto | |
| BR0314843A (pt) | Novo composto | |
| DE60301339D1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
| AR029343A1 (es) | USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN | |
| AR039177A1 (es) | Derivados de morfolina, antagonistas de ccr3. | |
| DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| NO20053956L (no) | Brystkreftresistentsprotein (BCRP)-inhibitor | |
| DE60122559D1 (de) | Indolderivate als pde5-inhibitoren | |
| SE0402284D0 (sv) | New heterocyclic amides | |
| ATE293111T1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren | |
| AR039176A1 (es) | Nuevo compuesto | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| SE0403118D0 (sv) | New compounds 2 | |
| ATE420860T1 (de) | N-substituierte amide als nk1 rezeptor antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |